This page provides links to notable biobanking publications. Each publication provides a link to PubMed, where papers can be retrieved.
D’Abramo, F. Biobank research, informed consent and society. Towards a new alliance? J Epidemiol Community Health 2015;0:1-4. A broad discussion on the rise of -omics disciplines and biobank research, and the ethical questions that ensue. An outline of a model of dynamic biobank consent is put forward.
Mascalzoni, D., Dove, E.S., Rubinstein, Y. et al. International Charter of principles for sharing bio-specimens and data. European Journal of Human Genetics 2014:1-8. This international charter provides the ethical foundations, a general MTA, and tools that may help, for data sharing.
Moore, H.M. Moving toward biospecimen harmonisation with evidence-based practices. Biopreservation and Biobanking. 2014; 12(2): 79-80. This one page article summarises challenges for harmonising biobanks.
Simeon-Dubach, D. and Watson, P. Biobanking 3.0: Evidence based and customer focused biobanking. Clinical biochemistry. 2014; 47: 300 – 308. This publication proposes a new focus for biobanking, which is centred on external stakeholders.
Vaught, J.E., Abayomi, A., Peakman, T. et al. Critical issues in International Biobanking. Clinical Chemistry. 2014; 60(11): 1368 – 1374. This opinion piece focuses on five biobanking experts’ views on issues that are important to international biobanking.
Watson, P.H., Nussbeck, S.Y., Carter, C. et al. A framework for biobank sustainability. Biopreservation and Biobanking. 2014; 12(1): 60 – 68. This publication discusses a proposed framework to encourage biobank sustainability, which includes three dimensions of biobanking: operational, social, and financial.
Cole, A, Cheah, S., Dee, S. et al. Biospecimen use correlates with emerging techniques in cancer research: Impact on planning future biobanks. Biopreservation and biobanking 2012; 10(6):518-525. There is an overall trend towards techniques requiring RNA products across all formats of biospecimens in basic cancer research. Aspre-analytical variables influence gene expression more than gene structure, care must be taken to minimise these variables.
Vaught, J.B., Henderson, M.K. and Compton, C.C. Biospecimens and biorepositories: From afterthought to science. Cancer epidemiology, biomarkers and prevention. 2012; 21: 253 – 255. This paper discusses the increasing focus on biospecimen quality and biobanking best practices.
Vaught, J. and Lockhart, N.C. The evolution of biobanking best practices. Clinica Chimica Acta. 2012; 413: 1569 – 1575. This paper discusses the reasons for best practices, and describes types of biobanking best practices and challenges ahead.
Hewitt, R. and Hainaut, P. Biobanking in a fast moving world: An international perspective. Journal of the National Cancer Institute Monographs. 2011; 42: 50 – 51. This brief paper describes attempts to network biobanks on an international scale.
Moore, H.M., Compton, C.C., Alper, J. et al. International approaches to advancing biospecimen science. Cancer Epidemiology, Biomarkers and Prevention. 2011; 20: 729 – 732. This is a good summary of the rapidly changing field of biospecimen science.
Morente, M. M., Cereceda, L., Luna-Crespo, F. et al. Managing a biobanking network. Biopreservation and biobanking. 2011; 9(2): 187 – 190. This publication discusses biobank networking in the context of the author’s expertise with a Spanish network.
Rogers, J., Carolin, T., Vaught, J. et al. Biobankonomics: A taxonomy for evaluating the economic benefits of standardised centralised human biobanking for translational research. Journal of the National Cancer Institute Monographs. 2011; 42: 32 – 38. This paper is one of two (see below) to introduce the term ‘biobankonomics’, and discusses financial sustainability for biobanks.
Vaught, J., Rogers, J., Carolin, T., et al. Biobankonomics: Developing a sustainable business model approach for the formation of a human tissue biobank. Journal of the National Cancer Institute Monographs. 2011; 42: 24 – 31. This ‘biobankonomics’ paper discusses financial sustainability for biobanks.
Watson, P.H. and Barnes, R.O. A proposed schema for classifying human research biobanks. Biopreservation and biobanking. 2011; 9(4): 327 – 333. This paper proposes a classification system for biobanks, based on access policy.
Grizzle, W.E., Bell, W.C. and Sexton, K.C. Issues in collecting, processing and storing human tissues and associated information to support biomedical research. Cancer biomarkers. 2010; 9(1-6): 531 – 549. This comprehensive overview of biobanking operations is authored by a leading biospecimen science researcher.
Hughes, S.E., Barnes, R.O., Watson, P.H. Biospecimen use in cancer research over two decades. Biopreservation and biobanking 2010; 8(2):89-97. This paper outlines trends in biospecimen usage from 1988 – 2008, and showed significant increases in cohort size, with a decrease in using frozen or fresh tissue alone. Predictions are for demand for biospecimens in cancer research to increase significantly, with the majority of studies based on FFPE or combination FFPE/frozen tissue cohorts.
Vaught, J.B., Caboux, E. and Hainaut, P. International efforts to develop biospecimen best practices. Cancer epidemiology, biomarkers and prevention. 2010; 19: 912 – 915. This paper provides a table of international biobanking best practice documents, as well as a short summary of the international obstacles to harmonisation.
Zatloukal, K. and Hainaut, P. Human tissue biobanks as instruments for drug discovery and development: impact of personalised medicine. Biomarkers in Medicine. 2010; 4(6): 895 – 903. This publication discusses the role that biobanks play in personalised medicine projects.
Bell, W.C., Sexton, K.C. and Grizzle, W.E. How to efficiently obtain human tissues to support specific biomedical research projects. Cancer epidemiology, biomarkers and prevention. 2009; 18:1676 – 1679. This commentary gives a summary of biobanking operations that pertain to tissue acquisition.